PMGC (NASDAQ:ELAB) Releases Earnings Results

PMGC (NASDAQ:ELAB) announced its earnings results on Friday. The company reported ($0.61) EPS for the quarter, FiscalAI reports. The business had revenue of $1.31 million for the quarter.

PMGC Trading Up 1.5%

NASDAQ:ELAB opened at $0.91 on Friday. The company has a market capitalization of $1.05 million, a P/E ratio of -0.01 and a beta of -0.25. The stock’s 50 day moving average price is $1.14 and its 200 day moving average price is $4.04. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.43 and a current ratio of 1.45. PMGC has a 52 week low of $0.84 and a 52 week high of $309.12.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a report on Friday, June 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.